Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

Recruiting

Early Phase 1

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related SymptomsPilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

Sponsor:

UCLA

Code:

NCT03991520

Conditions

Endometriosis

Anakinra

Markers of Inflammation

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

Anakinra 100Mg/0.67Ml Inj Syringe

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2021-05-28.